Study Plan and Module Guide

The Master Online Program Advanced Oncology is developed for working physicians and scientists. The concept "modulated time schedule" allows a temporal and local flexibility in arranging the workload. Further, a specific support-system and tutoring program will help you to organize your learning time and effort.

Module 2 ( ECTS Points: 11 )

Cellular and molecular biology of cancer is focusing on recent key aspects of translational research. The units vary from gene structure to cancer stem cells representing the broad spectrum of knowledge in cancerogenesis.

Diagnostics is summarizing all modern tools used for work-up of a patient with cancer. Benefits and limitations of imaging techniques up to molecular diagnostics are being discussed by means of case-based scenarios.

Module 3 ( ECTS Points: 10 )

Biometry focuses on key aspects of biostatistics and their application to the field of oncology. The units comprise study types, statistical tests, survival analysis, and sample size estimation for clinical trials in oncology. Online tutorials encourage the active application of the newly acquired knowledge via SPSS which is provided free of charge to all students of Ulm University.

The Clinical trials course delivers the toolbox for setting up, running and publishing a clinical trial. Aspects like quality assurance and transfer of study results into clinical practice are being discussed by examples from the CCCU-based clinical trials center.

The Ethical Aspects course deals with ethical principles for informed consent, biobanking, study participation, collaboration between stakeholders with a different background (academic/industry). Equally important is the unit on the prevention and the detection of scientific misconduct and fraud.

Module 4 ( ECTS Points: 11 )

Clinical Oncology I presents the current state of art and recent advances in the treatment of gynecological, urologic and gastrointestinal malignancies. Aspects of surgical intervention, radiotherapy and chemotherapy as well as targeted therapies are being discussed.

Clinical Oncology II presents the current state of art and recent advances in the treatment of – among others – thoracic, hematological and pediatric malignancies. Aspects of surgical intervention, radiotherapy and chemotherapy as well as targeted therapies for different disease entities are being discussed by experts in the field.

Management of processes, entities and people provides tools for assessing and improving leadership in oncology. This comprises classical topics such as practice and hospital management as well as behavioral economics.

Module 7: Master's Thesis ( ETCS Points: 15 )

Students should be able to: Perform an original scientific project in the field of Interdisciplinary Oncology, Clinical Research, Advanced Therapies and Integrated Concepts or Management. Students must summarize the data in a written report in the context of published data, critically discuss published data related to their project in a scientific presentation.

BSc degree or equivalent degree. Proof of the participation and successful passing of the Modules 1 and 2. In case of failure of one or more of the exams, the subject-specific board of examiners will decide if the student may apply for admission.

Two supervisors/examiners are required. At least one of both supervisors must be a member of Ulm University. Advisors working in the pharmaceutical industry may also take on supervision duities. All examiners have to be qualified for this duty, e.g. be a professor (equivalent to full or associate professors) or should be at the level of junior professors, junior group leaders or comparable. The Medical Faculty may grant the right to examine upon request.